drugset / Trial / NCT00146900

Prevention of Post Traumatic Stress Disorder by Early Treatment

NCT00146900 ↗

Completed 298 enrolled Hadassah Medical Organization
RandomizedParallel-groupSingle-blindPrevention

Summary

To prospectively evaluate the effect of early treatment (cognitive therapy (CT), cognitive-behavioral therapy (CBT) and escitalopram (SSRI) in preventing the occurrence of post-traumatic stress disorder in recent survivors of traumatic events.

Timeline

Start
2004-08
Primary completion
2008-01
Completion
2008-01

Outcome

Missed primary endpoint

paper The PTSD prevalence rates did not differ between the escitalopram and placebo subgroups (61.9% vs 55.6%; OR, 0.77 [95% CI, 0.21-2.77]). PMID 21969418 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 20 mg —